Ziplitics learned that the FDA's DHCoE recently released a call for feedback and a discussion paper exploring potential regulatory approaches for generative AI-enabled medical devices.
Published
Signal category
Research & Knowledge
Quote
“The FDA’s DHCoE recently released a rather interesting call for feedback and a discussion paper exploring potential regulatory approaches for generative AI-enabled medical devices.”
— Joshua Morriss, Ph.D.|Ziplitics team
Company
Ziplitics
Saving lives by eliminating delays in evidence-based research.
- Industry
- Research Services
- Location
- Midlothian, US
- Company size
- 5 employees
Ziplitics removes the cost and time barriers of preclinical and clinical research to produce PRISMA-/MDR-/IVDR-compliant, transparent, accurate and reliable insights that advance the health sciences and save lives. With the Literature Review Network (LRN), healthcare professionals go from hypothesis to complete study in under 500 minutes with high accuracy. LRN is Ziplitics’ explainable AI (XAI) platform that is now available for researchers and healthcare practitioners looking to reliably do systematic literature reviews, method development, meta-analyses, bioinformatics, HEOR, RWE research and more.
Founded 2023